PATENT CLAIM ANALYSIS

Application Number: 15890131
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "282000"]

Abstract:
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.

Claim (Index 12):
The pharmaceutical composition of  claim 1 , wherein the composition provides a Tmax for the epinephrine in a subject that is about 2 fold or less as compared to administration without alkylglycoside.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655669', '14133350', '12645376', '12341696', '13893219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8783653734932358
- 35 USC 102 Novelty (BERT): 0.5754918061606422
- Combined Prediction Score: 0.8480780167599764
- Mean Citation Score: 574.5939099999998
- Max Citation Score: 598.6614400000002
- Similarity Product: 360.7510157628633

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test